Jamil Khurram
Chief Medical Officer · 30 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-14 | GALT | GALECTIN THERAPEUTICS INC | Sale | 16,250 | $5.13 | $83,284.50 | filing |
| 2026-07-14 | GALT | GALECTIN THERAPEUTICS INC | Option exercise | 16,250 | $3.04 | $49,400.00 | filing |
| 2026-06-29 | GALT | GALECTIN THERAPEUTICS INC | Sale | 47,467 | $5.04 | $239,233.68 | filing |
| 2026-06-29 | GALT | GALECTIN THERAPEUTICS INC | Option exercise | 47,467 | $2.50 | $118,667.50 | filing |
| 2026-06-26 | GALT | GALECTIN THERAPEUTICS INC | Sale | 2,533 | $5.00 | $12,665.00 | filing |
| 2026-06-26 | GALT | GALECTIN THERAPEUTICS INC | Sale | 2,037 | $5.00 | $10,185.00 | filing |
| 2026-06-26 | GALT | GALECTIN THERAPEUTICS INC | Option exercise | 2,533 | $2.50 | $6,332.50 | filing |
| 2026-06-26 | GALT | GALECTIN THERAPEUTICS INC | Option exercise | 2,037 | $2.20 | $4,481.40 | filing |
| 2026-06-23 | GALT | GALECTIN THERAPEUTICS INC | Sale | 7,557 | $3.14 | $23,728.98 | filing |
| 2026-06-23 | GALT | GALECTIN THERAPEUTICS INC | Option exercise | 7,557 | $1.23 | $9,295.11 | filing |
| 2026-05-26 | GALT | GALECTIN THERAPEUTICS INC | Sale | 568 | $3.10 | $1,761.03 | filing |
| 2026-05-26 | GALT | GALECTIN THERAPEUTICS INC | Option exercise | 568 | $1.23 | $698.64 | filing |
| 2026-01-06 | GALT | GALECTIN THERAPEUTICS INC | Sale | 21,446 | $3.65 | $78,204.98 | filing |
| 2026-01-05 | GALT | GALECTIN THERAPEUTICS INC | Sale | 25,499 | $3.90 | $99,407.85 | filing |
| 2026-01-02 | GALT | GALECTIN THERAPEUTICS INC | Sale | 13,055 | $4.20 | $54,789.22 | filing |
| 2026-01-02 | GALT | GALECTIN THERAPEUTICS INC | Option exercise | 60,000 | $0.00 | $0.00 | filing |
| 2025-12-31 | GALT | GALECTIN THERAPEUTICS INC | Sale | 8,125 | $4.07 | $33,089.06 | filing |
| 2025-12-31 | GALT | GALECTIN THERAPEUTICS INC | Option exercise | 8,125 | $1.23 | $9,993.75 | filing |
| 2025-12-17 | GALT | GALECTIN THERAPEUTICS INC | Sale | 8,500 | $7.04 | $59,840.00 | filing |
| 2025-12-17 | GALT | GALECTIN THERAPEUTICS INC | Sale | 6,463 | $7.04 | $45,499.52 | filing |
| 2025-12-17 | GALT | GALECTIN THERAPEUTICS INC | Sale | 4,479 | $7.04 | $31,532.16 | filing |
| 2025-12-17 | GALT | GALECTIN THERAPEUTICS INC | Option exercise | 8,500 | $2.50 | $21,250.00 | filing |
| 2025-12-17 | GALT | GALECTIN THERAPEUTICS INC | Option exercise | 6,463 | $2.20 | $14,218.60 | filing |
| 2025-11-13 | GALT | GALECTIN THERAPEUTICS INC | Sale | 41,500 | $5.47 | $227,005.00 | filing |
| 2025-11-13 | GALT | GALECTIN THERAPEUTICS INC | Sale | 41,500 | $5.47 | $227,005.00 | filing |
| 2025-11-13 | GALT | GALECTIN THERAPEUTICS INC | Sale | 21,867 | $5.47 | $119,612.49 | filing |
| 2025-11-13 | GALT | GALECTIN THERAPEUTICS INC | Option exercise | 41,500 | $2.50 | $103,750.00 | filing |
| 2025-11-13 | GALT | GALECTIN THERAPEUTICS INC | Option exercise | 41,500 | $2.20 | $91,300.00 | filing |
| 2025-11-13 | GALT | GALECTIN THERAPEUTICS INC | Sale | 16,250 | $5.47 | $88,887.50 | filing |
| 2025-11-13 | GALT | GALECTIN THERAPEUTICS INC | Option exercise | 16,250 | $1.23 | $19,987.50 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.